Clinical Trial Update: Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow) [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and efficacy of Indocyanine Green–guided image-guided surgery for nervous system tumors (brain tumors) versus standard car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor Primary
• Brain Tumor Recurrent

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: University of Pennsylvania | Conditions: Brain Tumor, Primary, Brain Tumor, Recurrent | Phase 1 | Status: COMPLETED